chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got the breast cancer diagnosis after getting the vaccine (about May/June); This spontaneous case was reported by a consumer and describes the occurrence of BREAST CANCER (She got the breast cancer diagnosis after getting the vaccine (about May/June)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Depression and Blood pressure. Concomitant products included ATORVASTATIN for an unknown indication.   On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced BREAST CANCER (She got the breast cancer diagnosis after getting the vaccine (about May/June)) (seriousness criterion medically significant). The patient was treated with PALBOCICLIB (IBRANCE) ongoing since an unknown date for Breast cancer, at an unspecified dose and frequency. At the time of the report, BREAST CANCER (She got the breast cancer diagnosis after getting the vaccine (about May/June)) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications of the patient also included, blood pressure pill and antidepressant pill Patient was taking cancer treatment for breast cancer and a pill from Pfizer. Patient was diagnosed with breast cancer after getting the vaccine (about May/June). Patient took first dose on  0 14 2021 (unclear in the vaccination card).  Company Comment: This case concerns a  80-year-old, female patient with no relevant medical history, who experienced the unexpected event of Breast cancer. The event occurred at unknown interval after the second dose of mRNA-1273 (Moderna Covid-19 Vaccine). The rechallenge was unknown since no complete information about the first dose was disclosed. Limited information provided preclude a complete medical and causal assessment of this case. The benefit-risk relationship of mRNA-1273 (Moderna Covid-19 vaccine) is not affected by this report.; Sender's Comments: This case concerns a  80-year-old, female patient with no relevant medical history, who experienced the unexpected event of Breast cancer. The event occurred at unknown interval after the second dose of mRNA-1273 (Moderna Covid-19 Vaccine). The rechallenge was unknown since no complete information about the first dose was disclosed. Limited information provided preclude a complete medical and causal assessment of this case. The benefit-risk relationship of mRNA-1273 (Moderna Covid-19 vaccine) is not affected by this report.
Client c/o "generalized pain and lightheadedness and hot, was assisted to floor onto yoga mat, with feet elevated. VS taken 153/88 Pulse 109 SP02 100%, cold compresses applied. Verbal support provided, with no improvement and client c/o of "chest pain emergency called client remained alert and conscious was transported to local hospital via ambulance, departing VS @ 3:22pm 142/82 Pulse 109 SP02 100%, mother at side.
Screamed x 4 hours after vaccination non-stop. 101.5 temp x 2 day, fussy x 4-5 post vaccination.
Noted after immunization of varicella- Eczema like rash, red in 4 inch ring form.
Initial unsolicited report received from a nurse on 21-Jul-2015. A 40 years old female patient, had received first dose of ADACEL via intramuscular route in the right deltoid (batch number: C4730BA, expiry date and dose details were not provided) on 16-Jul-2015. There was no illness at the time of vaccination and no known pre-existing physician diagnosed allergies, birth defects and medical conditions. On 19-Jul-2015, 3 days post-vaccination, the patient developed a knot feeling in the right deltoid area at the injection site (20 mm diameter) with a reddened area (50 by 70 mm) which persisted till date. Laboratory investigations and corrective treatment were not provided. It was reported that she required ER/doctor visit. At the time of this report, the patient had not recovered from the above mentioned event. Documents held by sender: none. Follow up information received from a nurse on 18-Aug-2015. A patient received 0.5 ml dose of ADACEL (expiration date 24-Apr-2017) on 16-Jul-2015. It was reported that patient did not require any emergency room visit. Patient did not undergo any laboratory tests. On an unspecified date, the patient recovered from the events.
Case number PHEH2015US021305, is a combined initial and follow up spontaneous report received from a pharmacist on 20 Oct 2015. This report refers to a 59 year old male patient. Medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1515701) intramuscularly on 16 Oct 2015. It was reported that before vaccination the FLUVIRIN was exposed to 55 and 64 degree Fahrenheit temperature for 3 hours. No adverse event was reported following this maladministration.
Redness at injection site with small blisters. Itching, warm to touch. Swelling 3-4 inches in diameter.
The nurse administered the shot too high on my left shoulder. I experienced immediate pain in the shoulder that progressively worsened over the next few weeks. After a few weeks of trying to control the symptoms with OTC medications, I sought medical treatment. I was ultimately diagnosed with subacromial bursitis.
This spontaneous report was received from a medical assistant and refers to a female patient of an unknown age. No information regarding the patient's concurrent conditions, concomitant therapies and medical history was reported. On an unknown date in May 2017 (reported as "on 01-MAY-2017 or 09-MAY-2017"), the patient was vaccinated with PNEUMOVAX 23 lot# N003997, expiration date: 22-OCT-2018 (dose, route of administration were not reported). On an unknown date in May 2017 (reported as "on 02-MAY-2017 or 10-MAY-2017" and "the day after"), the patient experienced cellulitis on the back of her right arm. The patient sought medical attention and was treated with unspecified antibiotics. There was no lab diagnostic studies performed. The outcome of cellulitis was reported as not recovered. The causality between PNEUMOVAX 23 and cellulitis was not provided. Upon internal review, the event of cellulitis was considered to be medically significant. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA007145: US-009507513-1705USA009127.
Rash on upper body, fever, body aches,  vomiting, nausea
Ended up getting really sick like they had the flu; Bad ,Stronger reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Ended up getting really sick like they had the flu), VACCINATION SITE REACTION (Bad reaction) and INJECTION SITE REACTION (Stronger reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Ended up getting really sick like they had the flu), VACCINATION SITE REACTION (Bad reaction) and INJECTION SITE REACTION (Stronger reaction). At the time of the report, ILLNESS (Ended up getting really sick like they had the flu), VACCINATION SITE REACTION (Bad reaction) and INJECTION SITE REACTION (Stronger reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Dry Mouth; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 17Feb2021 15:45 (03:45 PM) (Batch/Lot Number: EM9809) as 2nd DOSE, SINGLE for covid-19 immunisation. The patient is not pregnant at the time of vaccination. The patient had no other vaccine in four weeks and taking other medications in two weeks (unspecified medications). The patient has no covid prior vaccination and not covid tested post vaccination. Medical history included Osteoporosis, pre-COPD and allergy to dye used in treadmill test all from an unknown date and unknown if ongoing. The patient previously took vicodin and experienced allergies. The patient also previously took bnt162b2 (Lot: EL9262) first dose on 27Jan2021 15:45 (03:45 PM) administered in Arm Left for covid-19 immunisation. It was reported that the patient experienced Dry Mouth on 19Feb2021 12:00 PM. No treatment was given for the reported event. The outcome of the event was not recovered.
1/10/2022 15:30 Patient presented to clinic for Moderna booster. Patient received dose of vaccine and within 5 minutes of being in observation patient complaints of feeling sweaty, dizzy, and changes to visual field. 15:35 Non clinical staff alerts RN to patient status and RN at patient side to start with history and physical exam. Water offered to patient.  Patient reiterates c/o dizziness increased, light headedness, and continuing changes to visual field. RN notes patient lips and skin pallor as pale and sweaty.  RN instructs patient to lay on ground where RN puts patient?s feet up on chair (semi reverse Trendelenburg). 15:37 Pulse ox placed on patients finger Sp02 97% (nail acrylic), HR 59, BP 82/48.  Patient pulse noted to be thready, patients skin clammy, and shirt noticeably saturated with sweat. RN asks patient pertinent medical history, meds, and allergies. Patient states no PMH besides oophorectomy which patient cannot state how long ago surgery was.  15:40 Patient in Same position ? vitals HR 51, Sp02 97% RA, BP 110/64. Patient states she is feeling better 15:43 and agrees to sitting up. Patient?s vitals sitting 108/60, HR 62, Sp02 99%. Patient then transferred from ground to chair, where vitals remained consistent BP 108/68. 15:50 Patient asked to stand with support at side ? HR 70 Sp02 96% and BP 110/70. Patient states no changes to visual, hearing, and no complaints of dizziness or lightheadedness. Patient states she feels better and is now at baseline. Patient offered transport and medical attention, Patient refuses. Patient also advised to contact support people for a ride. Patient again refuses against advice. RN advises patient to finish water and to continue to wait longer to make sure she is feeling better. 16:10 Patient leaves arena.
Increased heart rate, BP, loose stools, decreased appetite persisting to now. Stool improving somewhat. All else is over baseline.
This spontaneous report as received from a other health professional refers to a child received her first dose of VAQTA on 10-JUL-2014 and her second dose of VAQTA on 16-SEP-2014. The child has not reported or demonstrated any adverse effects. Additional information has been requested.
Caller states she got sick with Covid-19 around that time and recovered and tested negative after one week on 09MAY2021; Caller states she got sick with Covid-19 around that time while she and recovered and tested negative after one week on 09MAY2021; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 10Apr2021 as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient stated she was supposed to get her second dose on 01May2021, but she missed the dose as she got sick with Covid-19 around that time while and recovered and tested negative after one week on 09May2021. Now she wishes to get her second dose of the Pfizer BioNTech Covid-19 Vaccine. The patient underwent lab tests and procedures which included sars-cov-2 test which resulted negative on 09May2021. Outcome of the event Covid-19 was recovered on 09May2021.  Event occurred in a country different from that of the reporter. This may be a duplicate if the reporter also submitted directly to his/her local agency.  The lot number for BNT162b2 was not provided and will be requested during follow up.
I only had a sore arm the day of vaccination, Monday Jan 25, 2021, which was expected. No other side effects, and the sore arm was better by day 2.  On the 7th day after the vaccine, Monday February 1, 2021, I started to get a large red rash on my arm around the site of the injection. It is a little sore and itchy, and might be larger today. My doctor said (by email) that it is likely a delayed allergic reaction to the Moderna vaccine, and I should report it. She said it would clear up in about 2-7 days.  So, my arm was fine for the first 7 days, and only now I have the sore, itchy rash, about 3X5 inches on my arm at the injection site. No other side effects!
The case reported by a physician and described the occurrence of generalized urticaria in a 25 year old male pt who received Engerix B. On 22 July 2004, the pt received the first dose of Engerix B in the right arm (ENG5586A2). Approximately one day following the administration of Engerix B, on 23 July 2004, the pt experienced pruritus of the hands and fingers "that developed into urticaria all over the body." There was no localized reaction at the injection site. The pt was seen at a physician's office and was treated with steroids and diphenhydramine. The events resolved on 24 July 2004.
Mild reaction; itching; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Mild reaction) and PRURITUS (itching) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Mild reaction) and PRURITUS (itching). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ADVERSE REACTION (Mild reaction) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.   This case was linked to MOD-2021-110201 (Patient Link).
Began with facial pain in my cheeks where my cosmetic filler is. Then I woke up  on 23rd of December with facial swelling and a nodules in cheeks. Talked with one of the providers in the office and they said it has been happening to some with fillers. It literally happened over night. Still ongoing only day two.
This spontaneous report was received from a consumer concerning her daughter of unknown age. No concurrent conditions or pertinent medical history were reported. On an unknown date the patient was vaccinated with a dose of GARDASIL (dose number, dose and lot number not provided). No concomitant therapies were reported. On an unknown date the patient experienced an unspecified adverse event. The outcome of the adverse event was unknown. It was unspecified if the patient sought medical attention. There was no product quality complaint (PQC) involved. Additional information is not expected as no contact details were provided.
joint pain from the arm were the vaccine was received , to the elbow, knee, butt, hand; patient can't walk/ not able to move; This spontaneous case was reported by a non-health professional and describes the occurrence of ARTHRALGIA (joint pain from the arm were the vaccine was received , to the elbow, knee, butt, hand) and GAIT INABILITY (patient can't walk/ not able to move) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis.     Concurrent medical conditions included Diabetes (has diabetes). Concomitant products included METFORMIN for an unknown indication.    On 22-Sep-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Sep-2022, the patient experienced ARTHRALGIA (joint pain from the arm were the vaccine was received , to the elbow, knee, butt, hand) and GAIT INABILITY (patient can't walk/ not able to move). At the time of the report, ARTHRALGIA (joint pain from the arm were the vaccine was received , to the elbow, knee, butt, hand) and GAIT INABILITY (patient can't walk/ not able to move) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: X-RAYS, MRIs still going to a specialist in and out the hospital. On an unknown date, X-ray: X-RAYS, MRIs still going to a specialist in and out the hospital.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient called vaccination 4 days after receiving the vaccine started to experience joint pain from the arm were the vaccine was received, to the elbow, knee, butt, hand, patient can't walk. Symptoms are getting worse Without medication cannot move Caller has diabetes TREATMENT X-RAYS, MRIs still going to a specialist in and out the hospital and she is on steroids.
Numbness and tingling in left cheek, left jaw, and backs of both hands and calves, started shortly after flu shot. This is the third year experiencing these symptoms after the flu shot. They typically last about a week.
Hot and cold sweats. Unable to lift arm above head. Terrible migraine. Body aches. Nausea. Fever.
client passed out after vaccines completed, smelling salts adm and client awakened without incident, monitored for 15 minutes and then mother took her home to rest.  this has happened in the past and mother did not make staff aware of this prior to incident or administration of vaccines.  PPD was also administered in the left arm prior to vaccinations
On evening of Day 8 after Dose #1, right arm began to itch. On morning of Day 9, I noticed the area around. The vacccination became red, about 3 inches in diameter. It is now Day 11, and the redness  and itching  has not diminished.
Soreness in the arm at the injection site after first dose; Cold feet after first dose; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (Cold feet after first dose) and VACCINATION SITE PAIN (Soreness in the arm at the injection site after first dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Seafood allergy (shrimp), Dust allergy and Allergy to molds.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PERIPHERAL COLDNESS (Cold feet after first dose). On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness in the arm at the injection site after first dose). At the time of the report, PERIPHERAL COLDNESS (Cold feet after first dose) had not resolved and VACCINATION SITE PAIN (Soreness in the arm at the injection site after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-073780 (E2B Linked Report). This case was linked to MOD-2021-073780 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow-up was received and contains significant information: Patient's relevant history updated, contact details updated, patient information updated, event outcome added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073780:Dose 2
Client received a 'booster' dose erroneously. Client screed at registration by nurse, client reports he showed registration staff digital vaccine record which showed client had already received 2 doses of J&J. Client was sent to vaccine station were nurse administered pfizer vaccine. Client was then sent to observation unit where nurse providing education on post vaccine caught the error. Pod director was notified, I consulted with MD, we both spoke to client and informed him he received Pfizer dose when technically it was not indicated as per clients record he's already received 2 doses of J&J. Client verbalized understanding and states he wanted another shot because he knew that after a while he wasnt protected. MD explained yes he was correct and informed client he should be ok, but explained CDC guidance on this does not indicate a need for another booster after 1 booster of J&J. Provided client with education on what to expect post vaccine instructed client to monitor.
Terribly sick for 2 days; Initial information received on 09-Dec-2020 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.   This case involved an unknown demographic patient who experienced terribly sick for 2 days (Illness), while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, concomitant medication, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site.   On an unknown date, the patient experienced terribly sick for 2 days (Illness), unknown latency following the administration of INFLUENZA VACCINE.  Relevant laboratory test was not reported.  Final diagnosis was terribly sick for 2 days.   It was not reported if the patient received a corrective treatment.  The outcome was reported as Unknown for terribly sick for 2 days.  There would be no information available on batch number for this case.
Patient came to the pharmacy on the morning of 2/28/19 stating that starting the evening after her vaccination on 2/26/19, her left arm started hurting. The following day, she experienced more pain and limited mobility in that arm and the arm became red and swollen. She showed me the arm which did appear red and swollen, but not at the injection site, but lower and towards the inner arm. She stated that she had already made a doctor's appointment and would be going there, but wanted to let us know. I called the patient in the evening of 2/28/19 to check on her and how she had been treated by her physician. She stated that the physician gave her a steroid shot, a prescription for an antihistamine, and an antibiotic because he could not rule out infection.
Pt had headache that lasted up to 1 hour; 1 day post vax.
Initial report received from a physician on 29 October 2008.  A female patient (age and date of birth unknown) had received a dose of MENACTRA (lot number and route/site of administration unknown) on an unspecified date in July 2008.  On an unspecified date in August 2008, the patient began complaining of leg and ankle pain, which were ongoing at the time of the report.  A work-up is in progress.  Patient outcome was reported to be unknown.  No further information was provided.  Documents held by sender:  None